1. Home
  2. VALN vs LIND Comparison

VALN vs LIND Comparison

Compare VALN & LIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • LIND
  • Stock Information
  • Founded
  • VALN 2012
  • LIND 1979
  • Country
  • VALN France
  • LIND United States
  • Employees
  • VALN N/A
  • LIND N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • LIND Transportation Services
  • Sector
  • VALN Health Care
  • LIND Consumer Discretionary
  • Exchange
  • VALN Nasdaq
  • LIND Nasdaq
  • Market Cap
  • VALN 488.9M
  • LIND 549.2M
  • IPO Year
  • VALN 2021
  • LIND N/A
  • Fundamental
  • Price
  • VALN $4.66
  • LIND $13.12
  • Analyst Decision
  • VALN Strong Buy
  • LIND Strong Buy
  • Analyst Count
  • VALN 2
  • LIND 4
  • Target Price
  • VALN $18.50
  • LIND $14.25
  • AVG Volume (30 Days)
  • VALN 22.7K
  • LIND 353.4K
  • Earning Date
  • VALN 11-07-2024
  • LIND 11-05-2024
  • Dividend Yield
  • VALN N/A
  • LIND N/A
  • EPS Growth
  • VALN N/A
  • LIND N/A
  • EPS
  • VALN N/A
  • LIND N/A
  • Revenue
  • VALN $176,817,979.00
  • LIND $621,478,000.00
  • Revenue This Year
  • VALN $24.30
  • LIND $12.06
  • Revenue Next Year
  • VALN $16.05
  • LIND $9.27
  • P/E Ratio
  • VALN N/A
  • LIND N/A
  • Revenue Growth
  • VALN N/A
  • LIND 10.56
  • 52 Week Low
  • VALN $4.60
  • LIND $6.35
  • 52 Week High
  • VALN $12.85
  • LIND $14.34
  • Technical
  • Relative Strength Index (RSI)
  • VALN 26.32
  • LIND 69.39
  • Support Level
  • VALN $4.63
  • LIND $12.84
  • Resistance Level
  • VALN $5.28
  • LIND $13.81
  • Average True Range (ATR)
  • VALN 0.18
  • LIND 0.74
  • MACD
  • VALN -0.09
  • LIND 0.23
  • Stochastic Oscillator
  • VALN 4.05
  • LIND 76.40

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

About LIND Lindblad Expeditions Holdings Inc.

Lindblad Expeditions Holdings Inc provides expedition cruising and adventure travel services. The company operates in two segments: Lindblad and Land Experiences, of which Lindblad generates the vast majority of its revenue. It offers itineraries that feature up-close encounters with wildlife, nature, history, and culture, as well as promote guest empowerment and interactivity. It operates expeditions on intimately-scaled ships and interaction between guests, crew, and the teams of scientists, naturalists, researchers, and photographers that participate in the expeditions. Lindblad operates a fleet of nine owned expedition ships and five seasonal charter vessels under the Lindblad brand.

Share on Social Networks: